Colestasico
@colestasico.bsky.social
Reposted by Colestasico
🆕CPG❕
EASL-ERN Clinical Practice Guidelines on Wilson’s disease
✅Evidence-based recommendations for hepatologists, neurologists, GPs, pediatricians & all involved in #WD care
Full text here: bit.ly/42aw1vA
#LiverSky
@easlnews.bsky.social
#ERNRARE-LIVER
EASL-ERN Clinical Practice Guidelines on Wilson’s disease
✅Evidence-based recommendations for hepatologists, neurologists, GPs, pediatricians & all involved in #WD care
Full text here: bit.ly/42aw1vA
#LiverSky
@easlnews.bsky.social
#ERNRARE-LIVER
March 17, 2025 at 8:26 AM
🆕CPG❕
EASL-ERN Clinical Practice Guidelines on Wilson’s disease
✅Evidence-based recommendations for hepatologists, neurologists, GPs, pediatricians & all involved in #WD care
Full text here: bit.ly/42aw1vA
#LiverSky
@easlnews.bsky.social
#ERNRARE-LIVER
EASL-ERN Clinical Practice Guidelines on Wilson’s disease
✅Evidence-based recommendations for hepatologists, neurologists, GPs, pediatricians & all involved in #WD care
Full text here: bit.ly/42aw1vA
#LiverSky
@easlnews.bsky.social
#ERNRARE-LIVER
Reposted by Colestasico
📌Breakthroughs Beyond the Journal by David C. Trampert
Gut bacterial membrane components as pathogenic signalling molecules in PSC-IBD
Full text here👉https://doi.org/10.1016/j.jhep.2024.11.024
Refers to👉https://doi.org/10.1053/j.gastro.2024.06.032
#LiverSky
Gut bacterial membrane components as pathogenic signalling molecules in PSC-IBD
Full text here👉https://doi.org/10.1016/j.jhep.2024.11.024
Refers to👉https://doi.org/10.1053/j.gastro.2024.06.032
#LiverSky
Redirecting
doi.org
February 11, 2025 at 10:12 AM
📌Breakthroughs Beyond the Journal by David C. Trampert
Gut bacterial membrane components as pathogenic signalling molecules in PSC-IBD
Full text here👉https://doi.org/10.1016/j.jhep.2024.11.024
Refers to👉https://doi.org/10.1053/j.gastro.2024.06.032
#LiverSky
Gut bacterial membrane components as pathogenic signalling molecules in PSC-IBD
Full text here👉https://doi.org/10.1016/j.jhep.2024.11.024
Refers to👉https://doi.org/10.1053/j.gastro.2024.06.032
#LiverSky
Reposted by Colestasico
Our MARCH ISSUE is live! Gut-brain axis, probiotics, HCC precision models and strategies, and much more!
www.nature.com/nrgastro/vol...
www.nature.com/nrgastro/vol...
February 28, 2025 at 8:10 AM
Our MARCH ISSUE is live! Gut-brain axis, probiotics, HCC precision models and strategies, and much more!
www.nature.com/nrgastro/vol...
www.nature.com/nrgastro/vol...
Reposted by Colestasico
« Bulevirtide for the Treatment of Hepatitis Delta; Real-World Cohort from the Canadian HBV Network »
My poster at
CDDW-CLM conference
Quebec City 🇨🇦, now
*Nothing compared to European cohorts, but it’s a start. BLV only for compassionate use here 🤷♂️
#IDsky #Liversky #HepSky
My poster at
CDDW-CLM conference
Quebec City 🇨🇦, now
*Nothing compared to European cohorts, but it’s a start. BLV only for compassionate use here 🤷♂️
#IDsky #Liversky #HepSky
February 28, 2025 at 1:40 PM
Reposted by Colestasico
Itching sucks
If your patient with PBC is suffering from itch, it is time to kick it up a notch
There are too many options these days to let people continue scratching themselves sick
journals.lww.com/hepcomm/full... #liversky
If your patient with PBC is suffering from itch, it is time to kick it up a notch
There are too many options these days to let people continue scratching themselves sick
journals.lww.com/hepcomm/full... #liversky
March 3, 2025 at 10:26 PM
Itching sucks
If your patient with PBC is suffering from itch, it is time to kick it up a notch
There are too many options these days to let people continue scratching themselves sick
journals.lww.com/hepcomm/full... #liversky
If your patient with PBC is suffering from itch, it is time to kick it up a notch
There are too many options these days to let people continue scratching themselves sick
journals.lww.com/hepcomm/full... #liversky
Reposted by Colestasico
EBRUARY ISSUE | REVIEW "Immune-mediated liver injury from checkpoint inhibitors: mechanisms, clinical characteristics and management"
www.nature.com/articles/s41...
#Liversky
www.nature.com/articles/s41...
#Liversky
January 30, 2025 at 9:00 AM
EBRUARY ISSUE | REVIEW "Immune-mediated liver injury from checkpoint inhibitors: mechanisms, clinical characteristics and management"
www.nature.com/articles/s41...
#Liversky
www.nature.com/articles/s41...
#Liversky
Reposted by Colestasico
